Health Care & Life Sciences » Pharmaceuticals | Sinovac Biotech Ltd.

Sinovac Biotech Ltd.

Sinovac Biotech Ltd.
Stock Exchange NASDAQ Stock Market
EPS
$0.35
Market Cap
$383.81 M
Shares Outstanding
59.32 M
Public Float
37.94 M

Profile

Address
No. 15 Zhi Tong Road
Beijing Beijing 102200
China
Employees -
Website http://www.sinovacbio.com
Updated 07/08/2019
Sinovac Biotech Ltd. is a holding and biopharmaceutical company, which engages in the research, development, manufacturing, and commercialization of vaccines that protect against human infectious diseases including, without limitation, hepatitis A, hepatitis B, hand foot and mouth disease. It operates through the Mainland China and Hong Kong geographical segments. Its product pipelines include Healive, Bilive, Anflu, PANFLU.

Financials

View All

Wei Dong Yin
Chairman, President, CEO & Secretary
Guo Wei Wang
Director